EXCLUSIVE-AURINIA PHARMACEUTICALS FINDS NO BUYER, TO ANNOUNCE $150 MLN SHARE BUYBACK - SOURCES
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
5.455 USD | -0.09% | +1.21% | -39.43% |
Jun. 05 | Aurinia Pharmaceuticals Inc. Presents Safety and Efficacy Profile of LUPKYNIS® for People with Lupus Nephritis | CI |
Jun. 03 | Lucien Selce Sends Letter to Aurinia shareholders | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-39.43% | 779M | |
+18.04% | 125B | |
+13.88% | 109B | |
-3.35% | 24.74B | |
+2.71% | 22.67B | |
-9.95% | 18.14B | |
-41.48% | 16.67B | |
-12.10% | 16.64B | |
-0.14% | 13.45B | |
+21.74% | 11.32B |
- Stock Market
- Equities
- AUPH Stock
- News Aurinia Pharmaceuticals Inc.
- Aurinia Pharmaceuticals Finds No Buyer, To Announce $1…